Background/aims: Hepatitis C (HCV) infected patients have significant health-related quality of life (HRQL) impairment which worsens during anti-viral therapy. Our aim was to examine the association of HRQL with treatment-induced depression and anemia.
Methods: Two hundred and seventy-one HCV patients who received pegylated interferon alfa 2b and ribavirin were included.